Baxter International Inc.BAXNYSE
Loading
R&D Expenses Over TimeContracting
Percentile Rank7
3Y CAGR+4.8%
5Y CAGR-0.1%
Year-over-Year Change
Research and development spending
3Y CAGR
+4.8%/yr
vs -8.9%/yr prior
5Y CAGR
-0.1%/yr
Recent acceleration
Acceleration
+13.7pp
Accelerating
Percentile
P7
Near historical low
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $518.00M | -12.2% |
| 2024 | $590.00M | +13.9% |
| 2023 | $518.00M | +15.1% |
| 2022 | $450.00M | -15.3% |
| 2021 | $531.00M | +1.9% |
| 2020 | $521.00M | -12.4% |
| 2019 | $595.00M | -9.0% |
| 2018 | $654.00M | +6.3% |
| 2017 | $615.00M | -4.8% |
| 2016 | $646.00M | - |